Table 1. Comparison of baseline characteristics of patients with and without OBI.
Characteristic | Seropositive (n=11) |
Seronegative (n=18) |
p value | OBI-positive (n=11) |
OBI-negative (n=18) |
p value | Total (n=29) |
---|---|---|---|---|---|---|---|
Age (mean±SD) | 53±10 | 47±15 | 0.20 | 48±15 | 50±13 | 0.71 | 49±14 |
Female | 2 (18%) | 3 (17%) | 0.91 | 2 (18%) | 3 (17%) | 0.91 | 5 (17%) |
Male | 9 (82%) | 15 (83%) | 0.91 | 9 (82%) | 15 (83%) | 0.91 | 24 (83%) |
ALT (mean±SD) (Unit/mL) | 93±103 | 73±84 | 0.59 | 85±81 | 78±98 | 0.83 | 81±91 |
AST (mean±SD) (Unit/mL) | 96±126 | 72±66 | 0.56 | 82±72 | 80±105 | 0.95 | 81±92 |
Isolated Anti HBc+ | 7 (64%) | 0 | <0.001 | 3 (27%) | 4 (22%) | 0.75 | 7 (24%) |
Anti-HBs+ | 9 (82%) | 0 | <0.001 | 3 (27%) | 6 (33%) | 0.73 | 9 (31%) |
OBI+ | 4 (36%) | 7 (39%) | 0.89 | - | - | - | - |
OBI– | 7 (64%) | 11 (61%) | 0.89 | - | - | - | - |